These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 20133699)

  • 61. Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene.
    Demma MJ; Mapelli C; Sun A; Bodea S; Ruprecht B; Javaid S; Wiswell D; Muise E; Chen S; Zelina J; Orvieto F; Santoprete A; Altezza S; Tucci F; Escandon E; Hall B; Ray K; Walji A; O'Neil J
    Mol Cell Biol; 2019 Nov; 39(22):. PubMed ID: 31501275
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene.
    Bruno ME; West RB; Schneeman TA; Bresnick EH; Kaetzel CS
    Mol Immunol; 2004 Jan; 40(10):695-708. PubMed ID: 14644095
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ; Steingrìmsson E; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1999 Dec; 18(24):7019-28. PubMed ID: 10601024
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
    Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
    Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sequence specificity incompletely defines the genome-wide occupancy of Myc.
    Guo J; Li T; Schipper J; Nilson KA; Fordjour FK; Cooper JJ; Gordân R; Price DH
    Genome Biol; 2014; 15(10):482. PubMed ID: 25287278
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
    Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.
    Ottema S; Mulet-Lazaro R; Erpelinck-Verschueren C; van Herk S; Havermans M; Arricibita Varea A; Vermeulen M; Beverloo HB; Gröschel S; Haferlach T; Haferlach C; J Wouters B; Bindels E; Smeenk L; Delwel R
    Nat Commun; 2021 Sep; 12(1):5679. PubMed ID: 34584081
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma.
    Hu HM; Arcinas M; Boxer LM
    J Biol Chem; 2002 Mar; 277(12):9819-24. PubMed ID: 11777933
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells.
    Anderson DA; Murphy TL; Eisenman RN; Murphy KM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4885-4893. PubMed ID: 32071205
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The non-enzymatic RAS effector RASSF7 inhibits oncogenic c-Myc function.
    Kumaraswamy A; Mamidi A; Desai P; Sivagnanam A; Perumalsamy LR; Ramakrishnan C; Gromiha M; Rajalingam K; Mahalingam S
    J Biol Chem; 2018 Oct; 293(40):15691-15705. PubMed ID: 30139745
    [No Abstract]   [Full Text] [Related]  

  • 71. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells.
    Wang Q; Sun ZX; Allgayer H; Yang HS
    Oncogene; 2010 Jan; 29(1):128-38. PubMed ID: 19784072
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Mad and Myc basic domains are functionally equivalent.
    Nikiforov MA; Popov N; Kotenko I; Henriksson M; Cole MD
    J Biol Chem; 2003 Mar; 278(13):11094-9. PubMed ID: 12538578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C.
    Dryden NH; Broome LR; Dudbridge F; Johnson N; Orr N; Schoenfelder S; Nagano T; Andrews S; Wingett S; Kozarewa I; Assiotis I; Fenwick K; Maguire SL; Campbell J; Natrajan R; Lambros M; Perrakis E; Ashworth A; Fraser P; Fletcher O
    Genome Res; 2014 Nov; 24(11):1854-68. PubMed ID: 25122612
    [TBL] [Abstract][Full Text] [Related]  

  • 74. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter.
    Facchini LM; Chen S; Marhin WW; Lear JN; Penn LZ
    Mol Cell Biol; 1997 Jan; 17(1):100-14. PubMed ID: 8972190
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs.
    Allevato M; Bolotin E; Grossman M; Mane-Padros D; Sladek FM; Martinez E
    PLoS One; 2017; 12(7):e0180147. PubMed ID: 28719624
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.
    Xiang JF; Yin QF; Chen T; Zhang Y; Zhang XO; Wu Z; Zhang S; Wang HB; Ge J; Lu X; Yang L; Chen LL
    Cell Res; 2014 May; 24(5):513-31. PubMed ID: 24662484
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An enhancer from the 8q24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice.
    Ting MC; Liao CP; Yan C; Jia L; Groshen S; Frenkel B; Roy-Burman P; Coetzee GA; Maxson R
    Dis Model Mech; 2012 May; 5(3):366-74. PubMed ID: 22279083
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
    Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
    Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-range enhancers regulating Myc expression are required for normal facial morphogenesis.
    Uslu VV; Petretich M; Ruf S; Langenfeld K; Fonseca NA; Marioni JC; Spitz F
    Nat Genet; 2014 Jul; 46(7):753-8. PubMed ID: 24859337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.